Healthcare & Life Sciences Private Equity Deal Tracker: Carlyle and SK Capital to Acquire bluebird bio
JD Supra: Mergers
MARCH 4, 2025
Carlyle (NASDAQ: CG) and SK Capital Partners will acquire bluebird bio (NASDAQ: BLUE), according to a news release. bluebird, founded in 2010 and based in Somerville, Massachusetts, is a gene therapy maker. By: McGuireWoods LLP
Let's personalize your content